128 related articles for article (PubMed ID: 32501653)
1. Drug discontinuation in pregnant women with psoriasis: The PSO-MOTHER cohort study.
Belleudi V; Poggi FR; Perna S; Naldi L; Bortolus R; Rosa AC; Kirchmayer U; Davoli M; Addis A
Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):904-912. PubMed ID: 32501653
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use.
Carman WJ; Accortt NA; Anthony MS; Iles J; Enger C
Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1109-1118. PubMed ID: 28758274
[TBL] [Abstract][Full Text] [Related]
3. Use of tumor necrosis factor-alpha inhibitors during pregnancy among women who delivered live born infants.
Eworuke E; Panucci G; Goulding M; Neuner R; Toh S
Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):296-304. PubMed ID: 30430682
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.
Clowse ME; Feldman SR; Isaacs JD; Kimball AB; Strand V; Warren RB; Xibillé D; Chen Y; Frazier D; Geier J; Proulx J; Marren A
Drug Saf; 2016 Aug; 39(8):755-62. PubMed ID: 27282428
[TBL] [Abstract][Full Text] [Related]
5. Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study.
Viktil KK; Engeland A; Furu K
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):737-42. PubMed ID: 19504626
[TBL] [Abstract][Full Text] [Related]
6. Prescription drug use in pregnancy and variations according to prior psychiatric history.
Ingstrup KG; Liu X; Gasse C; Debost JP; Munk-Olsen T
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):105-113. PubMed ID: 29171114
[TBL] [Abstract][Full Text] [Related]
7. Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding.
Kurizky PS; Ferreira Cde C; Nogueira LS; Mota LM
An Bras Dermatol; 2015; 90(3):367-75. PubMed ID: 26131868
[TBL] [Abstract][Full Text] [Related]
8. Pharmaco-utilization of biologic drugs in patients affected by psoriasis, psoriatic arthritis and ankylosing spondylitis in an Italian real-world setting.
Zagni E; Colombo D; Fiocchi M; Perrone V; Sangiorgi D; Andretta M; De Sarro G; Nava E; Degli Esposti L
Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):491-497. PubMed ID: 32701033
[TBL] [Abstract][Full Text] [Related]
9. TNF-α inhibitor-induced psoriasis: A decade of experience at the Cleveland Clinic.
Mazloom SE; Yan D; Hu JZ; Ya J; Husni ME; Warren CB; Fernandez AP
J Am Acad Dermatol; 2020 Dec; 83(6):1590-1598. PubMed ID: 30576759
[TBL] [Abstract][Full Text] [Related]
10. Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts.
García-Doval I; Hernández MV; Vanaclocha F; Sellas A; de la Cueva P; Montero D;
Br J Dermatol; 2017 Mar; 176(3):643-649. PubMed ID: 27258623
[TBL] [Abstract][Full Text] [Related]
11. Patterns of medication use during pregnancy in rheumatoid arthritis.
Kuriya B; Hernández-Díaz S; Liu J; Bermas BL; Daniel G; Solomon DH
Arthritis Care Res (Hoboken); 2011 May; 63(5):721-8. PubMed ID: 21557526
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatments in pregnant women with psoriasis in the U.S.A.
Lin HC; Hunnicutt JN; Moustafa FA; Rohr AL; Huang KE; Balkrishnan R; Feldman SR
Br J Dermatol; 2015 Mar; 172(3):807-10. PubMed ID: 25070258
[No Abstract] [Full Text] [Related]
13. Psoriasis in pregnancy: a review (II).
Ruiz V; Manubens E; Puig L
Actas Dermosifiliogr; 2014 Nov; 105(9):813-21. PubMed ID: 24314892
[TBL] [Abstract][Full Text] [Related]
14. Treatment Patterns and Resource Utilization of Pregnant Women with Inflammatory Rheumatic Diseases or Psoriasis in Germany: A Claims Database Analysis.
Blaschke K; Fischer-Betz R; Marschall U; Dombrowsky W; Joeres L; Heidbrede T; Schubert I
Rheumatol Ther; 2021 Dec; 8(4):1565-1584. PubMed ID: 34427895
[TBL] [Abstract][Full Text] [Related]
15. Prescription-based prevalence of biological therapy in patients with psoriasis, rheumatoid arthritis, and inflammatory bowel diseases.
Kostev K; Madelung M
Biologicals; 2019 Sep; 61():52-54. PubMed ID: 31327630
[TBL] [Abstract][Full Text] [Related]
16. Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study.
Rebić N; Sayre EC; Zusman EZ; Amiri N; Baldwin C; De Vera MA
Rheumatology (Oxford); 2020 Jul; 59(7):1514-1521. PubMed ID: 31628479
[TBL] [Abstract][Full Text] [Related]
17. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
[TBL] [Abstract][Full Text] [Related]
18. Long-term etanercept retention patterns and factors associated with treatment discontinuation: a retrospective cohort study using Canadian claims-level data.
Khraishi M; Ivanovic J; Zhang Y; Millson B; Brabant MJ; Charland K; Woolcott J; Jones H
Clin Rheumatol; 2018 Sep; 37(9):2351-2360. PubMed ID: 29766376
[TBL] [Abstract][Full Text] [Related]
19. The impact of psoriasis on pregnancy outcomes.
Lima XT; Janakiraman V; Hughes MD; Kimball AB
J Invest Dermatol; 2012 Jan; 132(1):85-91. PubMed ID: 21918537
[TBL] [Abstract][Full Text] [Related]
20. Crossed looks on the dermatologist's position and the patient's preoccupations as to psoriasis and pregnancy: preliminary results of the PREGNAN-PSO study.
Maccari F; Fougerousse AC; Esteve E; Frumholtz L; Parier J; Hurabielle C; Cassius C; Taieb C;
J Eur Acad Dermatol Venereol; 2019 May; 33(5):880-885. PubMed ID: 30633377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
